Literature DB >> 29350757

Hepatoprotective Effects of Sophoricoside against Fructose-Induced Liver Injury via Regulating Lipid Metabolism, Oxidation, and Inflammation in Mice.

Wenfeng Li1, Yalong Lu2.   

Abstract

The dried fruit of Sophora japonica L. is a traditional Chinese herb tea rich in sophoricoside that is an isoflavone glycoside. The aim of current study was to investigate the hepatic protective effect of sophoricoside in high fructose (HF) diet fed mice. Healthy male mice were fed 30% fructose water and treated 80 and 160 mg/kg·bw sophoricoside continuously for 8 wk. Our data showed that administration of sophoricoside at 80 and 160 mg/kg·bw observably decreased the body weight and liver weight in HF-fed mice. It was found that the treatment of sophoricoside decreased the hepatic cholesterol and triglyceride levels, and serum low-density lipoprotein-cholesterol and apolipoprotein-B levels, and elevated the serum high-density lipoprotein-cholesterol and apolipoprotein-A1 levels. Moreover, the administration of sophoricoside decreased the HF-caused elevations of hepatic malonaldehyde, interleukin-1 and tumor necrosis factor-α levels, while increased the HF-induced decreases of hepatic superoxide dismutase and glutathione peroxidase activities. Meanwhile, serum aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase activities were reduced by treatment of sophoricoside in HF-fed mice. Histopathology of hematoxylin and eosin (H&E) and oil red O staining of liver tissues also confirmed the beneficial effects of sophoricoside against liver injury induced by HF-diet in mice. These findings indicated that sophoricoside may be a novel natural isoflavone for alleviating HF-induced liver injury. PRACTICAL APPLICATION: Fruit of Sophora japonica L. is a traditional herb tea and it recently becomes popular in China. Sophoricoside is an isoflavone glycoside (Genistein-4'-O-β-d-glucopyranoside) isolated from S. japonical L, and it possessed differential effects on the body health. The ingestion of sophoricoside or sophora fruit tea may be a novel strategy to prevent non-alcoholic fatty liver disease.
© 2018 Institute of Food Technologists®.

Entities:  

Keywords:  Sophoricoside; antioxidant; high fructose diet; hyperlipidemia; liver injury

Mesh:

Substances:

Year:  2018        PMID: 29350757     DOI: 10.1111/1750-3841.14047

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  7 in total

Review 1.  Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives.

Authors:  Howaida I Abd-Alla; Dalila Souguir; Mohamed O Radwan
Journal:  Arch Pharm Res       Date:  2021-12-15       Impact factor: 4.946

2.  Hepatic histopathology and apoptosis in diet-induced-obese mice under Escherichia coli pneumonia.

Authors:  Hetao Song; Zhicai Zuo; Zhuangzhi Yang; Caixia Gao; Kejie Chen; Jing Fang; Hengmin Cui; Ping Ouyang; Junliang Deng; Yi Geng; Hongrui Guo
Journal:  Aging (Albany NY)       Date:  2019-05-14       Impact factor: 5.682

3.  Consumption of post-fermented Jing-Wei Fuzhuan brick tea alleviates liver dysfunction and intestinal microbiota dysbiosis in high fructose diet-fed mice.

Authors:  Xiangnan Zhang; Qiu Wu; Yan Zhao; Alim Aimy; Xingbin Yang
Journal:  RSC Adv       Date:  2019-06-04       Impact factor: 3.361

4.  A metabolomic-based study on disturbance of bile acids metabolism induced by intratracheal instillation of nickel oxide nanoparticles in rats.

Authors:  Qiong Zhang; Xuhong Chang; Xiaoxia Wang; Haibing Zhan; Qing Gao; Mengmeng Yang; Han Liu; Sheng Li; Yingbiao Sun
Journal:  Toxicol Res (Camb)       Date:  2021-05-17       Impact factor: 3.524

5.  The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease

Authors:  İlknur Bingül; A. Fatih Aydın; Canan Küçükgergin; Işın Doğan-Ekici; Semra Doğru-Abbasoğlu; Müjdat Uysal
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

Review 6.  Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.

Authors:  Ayokanmi Ore; Oluseyi Adeboye Akinloye
Journal:  Medicina (Kaunas)       Date:  2019-01-24       Impact factor: 2.430

7.  Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.

Authors:  Maomao Gao; Fengjiao Hu; Hongliang Li; Lihua Zhu; Manli Hu; Yufeng Hu; Hongjie Shi; Guo-Jun Zhao; Chongshu Jian; Yan-Xiao Ji; Xiao-Jing Zhang; Zhi-Gang She
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.